Rayno BioBeat December 2020: Frothy Days Are Here Again-Momentum Traders Rule-Update 1
Update-1. 12/15...With Biden being declared a winner the focus of macro turns to stimulus talks and the FED Meeting tomorrow. The market ebullience returned today with all major indices up over 1%. The Pfizer vaccine is rolling out with Moderna expected next. With sellers holding off till 2021...
Healthcare Stocks Perk Up Amidst the Speculative Fervor-Risk On…Update-4…EDIT,SGMO.
Update-4 12/10....Nice snapback rally in NASDAQ up 0.54% with many nice moves in gene therapy from ASH. XBI up 3.69% ASH gives us two big wins : EDIT up 32% on IND application for sickle disease; Sangamo (SGMO) up 50% on Hemophilia A gene therapy. Gene therapy covered at JPM . Core biotech...
November Rally In Biotech with Small Caps Taking Off
November Rally in Biotech and with Broadening to Other Sectors Small caps taking off including XBI up 12%, IWM up 16.5% (11.2% YTD). Healthcare lagging a bit with the XLV up only 3.35% vs SPY up 7.5% (12.6% YTD). Re-openng trade movers: XLI up 14.75% at $88.11; XLE up 34.54% at $38.91. The...
Large Cap Biopharma Performance and Metrics Q3 2020; ETFs Are Winners-Update-3
Update-3 11/27 12p EST....Biotech rally underway with XBI at $130. Momentum market.IBB at 142.94.Small caps outpacing large caps. Vaccine stocks continue to run: BNTX, MRNA, NVAX. Gene editing movers : CRSP, EDIT, NTLA; mid caps strong. Large caps winners: AMGN VRTX Update-2 11/24..Another...
Re-Opening Trade is On Despite a Backdrop of COVID Cases Surging…Update-1
Update-1 11/20...a bit of a sell-off at the end of the day probably on Mnuchin "war of words" with FED on $500B. "Re-opening type" trades in XLF and XLI both down 0.9%;XLK down 1%. Materials doing well CLF, FCX; chips mixed slightly down. IBB and XBI up a tad; large cap winners...